Prognostic analysis of different postoperative adjuvant therapies for patients with hepatocellular carcinoma after radical resection with high-risk recurrence factors: a multicenter real-world retrospective study
Postoperative adjuvant therapy provides significant survival benefits for HCC patients with high risk of recurrence, with TACE therapy demonstrating the greatest efficacy. These findings underscore the importance of individualized postoperative management in this population.
Authors
- Jinlong Liu (ORCID: https://orcid.org/0000-0001-6248-9663)
- Zhi-Bin Zhao (ORCID: https://orcid.org/0000-0003-0691-2556)
- Hui Zhao (ORCID: https://orcid.org/0000-0002-1988-0197)
- Jian Li (ORCID: https://orcid.org/0000-0002-7977-664X)
- Chen-guang Su
- Yue Xiao
Institutions
- Hebei Medical University (CN)
- Tangshan People's Hospital (CN)
- Second Hospital of Hebei Medical University (CN)
- Chengde Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-10-22
- DOI
- https://doi.org/10.3389/fimmu.2025.1661923
- Citations
- 1
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 1.32
Funders
- Natural Science Foundation of Hebei Province